Showing results (5951-5960 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|March 2, 2011
Role of polyunsaturated fatty acids and fatty acid binding protein in the pathogenesis of schizophreniaMotoko Maekawa, Yuji Owada, Takeo YoshikawaCurrent Pharmaceutical Design|March 2, 2011
α7 nicotinic acetylcholine receptor as a potential therapeutic target for schizophreniaMasatomo Ishikawa, Kenji HashimotoCurrent Pharmaceutical Design|March 8, 2011
Role of nitric oxide in motor control: implications for Parkinson's disease pathophysiology and treatmentElaine Del-Bel, Fernando Eduardo Padovan-Neto, Rita Raisman-Vozari, et al.Current Pharmaceutical Design|March 8, 2011
Identification of new drug targets and biomarkers related to obesity and eating disorders: an approach based on reward deficit and addictionLuis F Alguacil, Elisabet Salas, Carmen González-MartínCurrent Pharmaceutical Design|March 8, 2011
Lipogenic enzymes as therapeutic targets for obesity and diabetesJames M LenhardCurrent Pharmaceutical Design|April 12, 2011
Hypocretin antagonists in insomnia treatment and beyondChad Ruoff, Michelle Cao, Christian GuilleminaultCurrent Pharmaceutical Design|April 8, 2011
Caenorhabditis elegans-based model systems for antifungal drug discoveryCleo G Anastassopoulou, Beth Burgwyn Fuchs, Eleftherios MylonakisCurrent Pharmaceutical Design|April 16, 2011
Taxation as prevention and as a treatment for obesity: the case of sugar-sweetened beveragesNicole L Novak, Kelly D BrownellCurrent Pharmaceutical Design|April 16, 2011
Addiction liability of pharmacotherapeutic interventions in obesityWilliam M Greene, Mark Sylvester, Joel AbrahamCurrent Pharmaceutical Design|April 16, 2011
The role of food addiction in clinical researchAshley N Gearhardt, William R CorbinPageof 1,008